- Hormonal contraceptives and venous thromboembolism: an epidemiological updateGenevieve Plu-Bureau
Department of Gynecology and Endocrinology, Hôpital Universitaires Paris Centre, Paris Descartes University, Paris, France
Best Pract Res Clin Endocrinol Metab 27:25-34. 2013..In conclusion, newer generation formulations of hormonal contraceptives, as well as the non-oral hormonal contraceptive, seem to be more thrombogenic than second generation hormonal contraceptives...
- Hormonal contraceptives and arterial disease: an epidemiological updateGenevieve Plu-Bureau
Department of Gynecology and Endocrinology, Hôpital Universitaire Paris Centre, Paris Descartes University, Paris, France
Best Pract Res Clin Endocrinol Metab 27:35-45. 2013..23 for MI risk and 0.99 for ischemic stroke). In conclusion, newer generation formulations of COCs, as well as the non-oral hormonal contraceptive, do not seem to be safer than second generation hormonal contraceptives...
- Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of ProgestogenMarianne Canonico
From the Université Paris Saclay, Univ Paris Sud, UVSQ, Centre de Recheche en Epidémiologie et Santé des Populations, Inserm UMRS1018, Villejuif, France M C, E O, A S M, A E, P Y S Institut de veille sanitaire InVS, Département des Maladies Chroniques et des, Traumatismes, F 94415 Saint Maurice, France L C APHP, Hôpitaux Paris Centre, Unité de gynécologie endocrinienne, Paris, 75014, France et Université Paris Descartes G P B Université Paris Saclay, Univ Paris Sud, UVSQ, Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, INSERM UMRS1181, Villejuif, France P T B and Institut Pasteur, Paris, France P T B
Stroke 47:1734-41. 2016..However, the differential association of oral and transdermal estrogens with stroke remains poorly investigated. Furthermore, there are no data regarding the impact of progestogens...
- Epidemiology of hormonal contraceptives-related venous thromboembolismJustine Hugon-Rodin
Department of Gynecology and EndocrinologyHôpitaux Universitaires Paris Centre, Paris Descartes University, Paris, France
Eur J Endocrinol 171:R221-30. 2014..Further studies are needed to conclude on the combinations containing NGM or low doses of EE associated with GSD. ..
- Are we overestimating the stroke risk related to contraceptive pills?Anne Gompel
Unité de gynécologie endocrinienne, Universite Paris Descartes, Hôpitaux Universitaires Paris Centre, APHP, Paris, France
Curr Opin Neurol 27:29-34. 2014..Given the benefits associated with combined hormonal contraceptives (COCs), it is important to properly evaluate their risks in order to provide a better benefit/risk balance to young women...
- Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) studyGregoire Le Gal
Unit 258, Institut National de la Sante et de la Recherche Medicale, Paris, France
Atherosclerosis 166:163-70. 2003..Information on the impact of hormone replacement therapy (HRT) on carotid atherosclerosis is limited. Moreover, transdermal estrogens have not been investigated...
- Death-associated protein kinase loss of expression is a new marker for breast cancer prognosisDelphine Lévy
Unité de gynécologie endocrinienne, Hopital Hotel Dieu, Paris, France
Clin Cancer Res 10:3124-30. 2004..We analyzed the level of DAP-kinase expression in breast cancer specimens and its correlation with survival...
- Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysisZeina Chakhtoura
Department of Gynecology and Endocrinology, Hopital Hotel Dieu, Assistance Publique Hopitaux de Paris, Paris Descartes University, 75004 Paris, France
J Clin Endocrinol Metab 96:1169-74. 2011..While progestogen-only contraceptives (POC) are commonly used worldwide, their impact on cardiovascular diseases is poorly investigated and remains unclear...